相关实验视频
Updated: May 13, 2026
16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.2K
作为左心室辅助器件植入结果的预后生物标志物,加勒-3作为预后生物标志物
Ryan Hoang1, Mary E Acosta2, Mark N Belkin2
1From the Department of Surgery, Section of Cardiac Surgery, University of Chicago, Chicago, Illinois.
ASAIO journal (American Society for Artificial Internal Organs : 1992)
|August 1, 2024
概括
盖莱克-3作为心力衰竭患者的预测生物标志物,具有左心室辅助器件 (LVADs) 的患者,显示出有前途. 它与关键结果相关,并改善了预测右心力衰竭 (RHF) 的风险得分.
科学领域:
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
- 医疗器械 医疗器械
背景情况:
- 左心室辅助器件 (LVAD) 对于末期心力衰竭管理至关重要.
- 在LVAD植入后预测诸如右心力衰竭 (RHF) 和不良事件等结果仍然具有挑战性.
- 加勒-3正在研究其在心脏病进展中的作用.
研究的目的:
- 评估Galectin-3在LVAD患者的预后潜力.
- 评估加勒-3与临床结果的相关性,包括RHF,血红相容性相关不良事件 (HRAE) 和死亡率.
- 为了确定加勒-3是否改善了现有的风险评分,用于RHF预测.
主要方法:
- 分析了接受LVAD (2012-2020) 的159名心力衰竭患者的队列.
- 测量了加勒-3水平,并与血液动力学数据,RHF,HRAE,死亡率和其他临床参数相关联.
- 加勒-3被纳入密歇根-RVF和EUROMACS-RHF风险评分中进行比较分析.
主要成果:
- 盖列-3与RHF显著相关,内持续时间,ICU停留时间,BUN,肌素和肺动脉脉动指数.
- 加勒-3的加入改善了密歇根-RVF (0.80-0.86) 和EUROMACS-RHF (0.77-0.82) 两种评分中的RHF的预测准确性 (c-统计).
- 升高的加列-3 (>18.2 ng/mL) 与HRAE和死亡率有显著的关联.
结论:
- 加勒-3在LVAD患者中显示出显著的预后价值.
- 这种生物标志物增强了已建立的RHF风险评分的预测能力.
- 加勒-3作为一种有价值的预测生物标志物,可用于管理LVAD接受者.
相关概念视频
01:24Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...